GP
AGX icon

Geneva Partners’s Argan AGX Stock Holding History

Geneva Partners’s Portfolio AGX Stock Details AGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.68M Buy
+4,603
New +$3.06M 0.98% 32

Other funds holding AGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return

Geneva Partners's AGX Position: Q2 2026 in Review

Geneva Partners opened a new position in Argan (AGX) in Q2 2026: 4,603 shares worth $3.68M. The stake represents 0.98% of the portfolio and ranks #32 among its holdings.

562 funds tracked by Wall St. Rank hold AGX as of Q2 2026.

  • Geneva Partners held 4,603 shares of Argan worth $3.68M as of Q2 2026.
  • Argan was a new Geneva Partners position in Q2 2026.
  • Argan made up 0.98% of Geneva Partners's portfolio in Q2 2026, its #32 holding.
  • 562 funds tracked by Wall St. Rank held Argan as of Q2 2026.

Based on Geneva Partners's 13F filing for Q2 2026, filed 10 Aug 2026.